The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. The secondary endpoint of this trial will be to evaluate if a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and insulinemia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Enrollment
23
500 mg (in two 250 mg capsules) taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)
Two capsules similar in aspect and weight to active product, taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)
Institut des Nutraceutiques et des Aliments Fonctionnels (INAF)
Québec, Quebec, Canada
Safety of a single 500 mg administration of a brown seaweed extract in human
Time frame: First administration up to 7 days after last administration
Significant reduction of glycemic index of test food
Time frame: Immediately after product administration (single use)
Significant reduction in postprandial glycemia
Time frame: Immediately after product administration (single use)
Significant reduction in postprandial insulinemia
Time frame: Immediately after product administration (single use)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.